157 related articles for article (PubMed ID: 30548527)
1. Poly-allylamine hydrochloride and fucoidan-based self-assembled polyelectrolyte complex nanoparticles for cancer therapeutics.
Wang P; Kankala RK; Chen B; Long R; Cai D; Liu Y; Wang S
J Biomed Mater Res A; 2019 Feb; 107(2):339-347. PubMed ID: 30548527
[TBL] [Abstract][Full Text] [Related]
2. Enzymatic stimuli-responsive methotrexate-conjugated magnetic nanoparticles for target delivery to breast cancer cells and release study in lysosomal condition.
Nosrati H; Mojtahedi A; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2018 Jun; 106(6):1646-1654. PubMed ID: 29441671
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of folic acid functionalized bioactive glass for targeted delivery and sustained release of methotrexate.
Chen J; Chen X; Yang Z; Tan X; Wang J; Chen Y
J Biomed Mater Res A; 2019 Feb; 107(2):319-329. PubMed ID: 30450695
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.
Nosrati H; Adinehvand R; Manjili HK; Rostamizadeh K; Danafar H
Pharm Dev Technol; 2019 Jan; 24(1):89-98. PubMed ID: 29307260
[TBL] [Abstract][Full Text] [Related]
5. pH/redox responsive core cross-linked nanoparticles from thiolated carboxymethyl chitosan for in vitro release study of methotrexate.
Gao C; Liu T; Dang Y; Yu Z; Wang W; Guo J; Zhang X; He G; Zheng H; Yin Y; Kong X
Carbohydr Polym; 2014 Oct; 111():964-70. PubMed ID: 25037437
[TBL] [Abstract][Full Text] [Related]
6. Bioreducible cross-linked core polymer micelles enhance in vitro activity of methotrexate in breast cancer cells.
Gulfam M; Matini T; Monteiro PF; Riva R; Collins H; Spriggs K; Howdle SM; Jérôme C; Alexander C
Biomater Sci; 2017 Feb; 5(3):532-550. PubMed ID: 28124699
[TBL] [Abstract][Full Text] [Related]
7. Octreotide-conjugated PAMAM for targeted delivery to somatostatin receptors over-expressed tumor cells.
Peng J; Qi X; Chen Y; Ma N; Zhang Z; Xing J; Zhu X; Li Z; Wu Z
J Drug Target; 2014 Jun; 22(5):428-38. PubMed ID: 24437350
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic Y shaped miktoarm star copolymer for anticancer hydrophobic and hydrophilic drugs codelivery: Synthesis, characterization, in vitro, and in vivo biocompatibility study.
Aghajanzadeh M; Zamani M; Rashidzadeh H; Rostamizadeh K; Sharafi A; Danafar H
J Biomed Mater Res A; 2018 Nov; 106(11):2817-2826. PubMed ID: 29908009
[TBL] [Abstract][Full Text] [Related]
9. Lipid and TPGS based novel core-shell type nanocapsular sustained release system of methotrexate for intravenous application.
Katiyar SS; Kushwah V; Dora CP; Jain S
Colloids Surf B Biointerfaces; 2019 Feb; 174():501-510. PubMed ID: 30497012
[TBL] [Abstract][Full Text] [Related]
10. Development of both methotrexate and mitomycin C loaded PEGylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect.
Jia M; Li Y; Yang X; Huang Y; Wu H; Huang Y; Lin J; Li Y; Hou Z; Zhang Q
ACS Appl Mater Interfaces; 2014 Jul; 6(14):11413-23. PubMed ID: 24977925
[TBL] [Abstract][Full Text] [Related]
11. Preparation and characterization of methotrexate-loaded microcapsules.
Genç L; Büyüktıryakı S
Pharm Dev Technol; 2014 Feb; 19(1):42-7. PubMed ID: 23368981
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.
Rasouli S; Davaran S; Rasouli F; Mahkam M; Salehi R
Drug Deliv; 2014 May; 21(3):155-63. PubMed ID: 24107075
[TBL] [Abstract][Full Text] [Related]
13. in vitro- and in vivo Evaluation of Methotrexate-Loaded Hydrogel Nanoparticles Intended to Treat Primary CNS Lymphoma via Intranasal Administration.
Pourtalebi Jahromi L; Mohammadi-Samani S; Heidari R; Azadi A
J Pharm Pharm Sci; 2018; 21(1):305-317. PubMed ID: 30053381
[TBL] [Abstract][Full Text] [Related]
14. Novel biosurfactant and lipid core-shell type nanocapsular sustained release system for intravenous application of methotrexate.
Katiyar SS; Kushwah V; Dora CP; Jain S
Int J Pharm; 2019 Feb; 557():86-96. PubMed ID: 30584909
[TBL] [Abstract][Full Text] [Related]
15. Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.
Lin L; Xu W; Liang H; He L; Liu S; Li Y; Li B; Chen Y
Colloids Surf B Biointerfaces; 2015 Feb; 126():459-66. PubMed ID: 25601095
[TBL] [Abstract][Full Text] [Related]
16. Poly (ɛ-Caprolactone) Nanoparticles with pH-Responsive Behavior Improved the In Vitro Antitumor Activity of Methotrexate.
Macedo LB; Nogueira-Librelotto DR; de Vargas J; Scheeren LE; Vinardell MP; Rolim CMB
AAPS PharmSciTech; 2019 Apr; 20(5):165. PubMed ID: 30993464
[TBL] [Abstract][Full Text] [Related]
17. Development of methotrexate loaded fucoidan/chitosan nanoparticles with anti-inflammatory potential and enhanced skin permeation.
Barbosa AI; Costa Lima SA; Reis S
Int J Biol Macromol; 2019 Mar; 124():1115-1122. PubMed ID: 30521895
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier.
Attari E; Nosrati H; Danafar H; Kheiri Manjili H
J Biomed Mater Res A; 2019 Nov; 107(11):2492-2500. PubMed ID: 31298774
[TBL] [Abstract][Full Text] [Related]
19. Preparation, characterization and in vitro antitumor activity evaluation of hyaluronic acid-alendronate-methotrexate nanoparticles.
Gao C; Wang M; Zhu P; Yan C
Int J Biol Macromol; 2021 Jan; 166():71-79. PubMed ID: 33091477
[TBL] [Abstract][Full Text] [Related]
20. Integration of phospholipid-hyaluronic acid-methotrexate nanocarrier assembly and amphiphilic drug-drug conjugate for synergistic targeted delivery and combinational tumor therapy.
Li Y; Zhang H; Chen Y; Ma J; Lin J; Zhang Y; Fan Z; Su G; Xie L; Zhu X; Hou Z
Biomater Sci; 2018 Jun; 6(7):1818-1833. PubMed ID: 29785434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
